and GlaxoSmithKline in November 2009 with both companies transferring their HIV assets to the new company. In 2012 Shionogi joined the... company. 76.5% of the company is now owned by GlaxoSmithKline, 13.5% by Pfizer and 10% by Shionogi...
GSK remains committed to achieving bold commercial ambitions for the future. Our Ahead Together strategy is centered on early intervention to prevent and alter the course of disease, thereby protecting people and supporting healthcare syste...
At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the imm...
Region: Los Angeles, CA ViiV Healthcare is a global specialty HIV company, the only one that is 100% focused on researching and delivering new medicines for people living with, and at risk of, HIV. ViiV Healthcare is highly mission-driven...
Business Introduction We manufacture and supply reliable, high-quality medicines and vaccines to meet patients’ needs and drive our performance. Our network of 37 medicines and vaccines manufacturing sites delivered 1.7 billion packs of me...
Business Introduction We manufacture and supply reliable, high-quality medicines and vaccines to meet patients’ needs and drive our performance. Our network of 37 medicines and vaccines manufacturing sites delivered 1.7 billion packs of m...
Are you a curious analytics professional interested in driving performance of our Specialty Business Unit (SBU)? The Manager, Business Analytics will work on the SBU Insights & Analytics team to develop and execute commercial analyses that ...
GSK seeks an outstanding leader in clinical development to join as VP Clinical Research Head (CRH), Nephrology within the Advanced Portfolio Unit. The Advanced Portfolio Unit works within the Respiratory, Immunology and Inflammation Researc...
Principal Scientist, Drug Product Steriles Primary Packaging Onsite role located at Upper Providence, PA At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade....
ViiV Healthcare is a global specialty HIV company, the only one that is 100% focused on researching and delivering new medicines for people living with, and at risk of, HIV. ViiV is highly mission-driven in our unrelenting commitment to bei...